Cited by 77Neuroinflammation and Neurodegeneration MechanismsTryptophan and brain disordersThermal Regulation in Medicine

Correction: A Systematic Analysis of the Peripheral and CNS Effects of Systemic LPS, IL-1Β, TNF-α and IL-6 Challenges in C57BL/6 Mice

Open access
Skelly, Donal T., Hennessy, Edel, Dansereau, Marc-Andre, Cunningham, Colm·2013·PLoS ONE

Abstract

It is increasingly clear that systemic inflammation has both adaptive and deleterious effects on the brain.However, detailed comparisons of brain effects of systemic challenges with different pro-inflammatory cytokines are lacking.In the present study, we challenged female C57BL/6 mice intraperitoneally with LPS (100 µg/kg), IL-1β (15 or 50 µg/kg), TNF-α (50 or 250 µg/kg) or IL-6 (50 or 125 µg/kg).We investigated effects on core body temperature, open field activity and plasma levels of inflammatory markers at 2 hours post injection.We also examined levels of hepatic, hypothalamic and hippocampal inflammatory cytokine transcripts.Hypothermia and locomotor hypoactivity were induced by LPS>IL-1β>TNF-α>>IL-6.Systemic LPS, IL-1β and TNF-α challenges induced robust and broadly similar systemic and central inflammation compared to IL-6, which showed limited effects, but did induce a hepatic acute phase response.Important exceptions included IFNβ, which could only be induced by LPS.Systemic IL-1β could not induce significant blood TNF-α, but induced CNS TNF-α mRNA, while systemic TNF-α could induce IL-1β in blood and brain.Differences between IL-1β and TNF-α-induced hippocampal profiles, specifically for IL-6 and CXCL1 prompted a temporal analysis of systemic and central responses at 1, 2, 4, 8 and 24 hours, which revealed that IL-1β and TNF-α both induced the chemokines CXCL1 and CCL2 but only IL-1β induced the pentraxin PTX3.Expression of COX-2, CXCL1 and CCL2, with nuclear localisation of the p65 subunit of NFκB, in the cerebrovasculature was demonstrated by immunohistochemistry. Furthermore, we used cFOS immunohistochemistry to show that LPS, IL-1β and to a lesser degree, TNF-α activated the central nucleus of the amygdala.Given the increasing attention in the clinical literautre on correlating specific systemic inflammatory mediators with neurological or neuropsychiatric conditions and complications, these data will provide a useful resource on the likely CNS inflammatory profiles resulting from systemic elevation of particular cytokines.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/annotation/90c76048-2edd-4315-8404-4d9d8cbd411e

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MoMg that derive from HSC expressing the DNMT3A R822H variant cause a motor impairment reminiscent of the hypokinetic motor phenotype seen in parkinsonism.

    “Specifically, using a BM transfer model, we show that MoMg that derive from HSC that express the DNMT3A R822H variant cause a motor impairment reminiscent of the hypokinetic motor phenotype seen in parkinsonism 72 .”

    From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [72]

    The Sickness behaviour section (page unavailable) reports reduced locomotor activity after systemic inflammatory challenges in mice, not a parkinsonian motor phenotype. The passages found for DNMT3A R822H, bone-marrow transfer, and hypokinetic parkinsonism do not address the comparison for which this citation appears to be offered; the variant-specific result is framed as the citing authors’ own finding. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 77

  1. Steinman L (2004) Elaborate interactions between the immune and nervous systems. Nat Immunol 5: 575-581. doi:10.1038/ni1078. PubMed: 15164017. · DOI · Paper page
  2. Konsman JP, Parnet P, Dantzer R (2002) Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25: 154-159. doi:10.1016/S0166-2236(00)02088-9. PubMed: 11852148. · DOI · Paper page
  3. Dantzer R (2004) Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 500: 399-411. doi:10.1016/j.ejphar.2004.07.040. PubMed: 15464048. · DOI · Paper page
  4. Dantzer R (2001) Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 15: 7-24. doi:10.1006/brbi.2000.0613. PubMed: 11259077. · DOI · Paper page
  5. Dantzer R (2009) Cytokine, Sickness Behavior, and Depression 29. Immunology and Allergy Clinics of North America. pp. 247-264.
  6. Inui A (2001) Cytokines and sickness behavior: implications from knockout animal models. Trends Immunol 22: 469-473. doi:10.1016/ S1471-4906(01)01981-0. PubMed: 11525927. · DOI
  7. Wang J, Ando T, Dunn AJ (1997) Effect of homologous interleukin-1, interleukin-6 and tumor necrosis factor-alpha on the core body temperature of mice. Neuroimmunomodulation 4: 230-236. PubMed: 9650815.
  8. Swiergiel AH, Dunn AJ (1999) The roles of IL-1, IL-6, and TNFalpha in the feeding responses to endotoxin and influenza virus infection in mice. Brain Behav Immun 13: 252-265. doi:10.1006/brbi.1999.0565. PubMed: 10469526. · DOI
  9. Luterman JD, Haroutunian V, Yemul S, Ho L, Purohit D et al. (2000) Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol 57: 1153-1160. doi:10.1001/ archneur.57.8.1153. PubMed: 10927795. · DOI · Paper page
  10. Miller AH, Maletic V, Raison CL (2009) Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression. Biol Psychiatry 65: 732-741. doi:10.1016/j.biopsych. 2008.11.029. PubMed: 19150053. · DOI · Paper page
  11. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L et al. (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67: 446-457. doi:10.1016/j.biopsych.2009.09.033. PubMed: 20015486. · DOI · Paper page
  12. Swardfager W, Lanctôt K, Rothenburg L, Wong A, Cappell J et al. (2010) A Meta-Analysis of Cytokines in Alzheimer's Disease. Biol Psychiatry 68: 930-941. doi:10.1016/j.biopsych.2010.06.012. PubMed: 20692646. · DOI · Paper page
  13. Chen H, O'Reilly EJ, Schwarzschild MA, Ascherio A (2008) Peripheral Inflammatory Biomarkers and Risk of Parkinson's Disease. Am J Epidemiol 167: 90-95. PubMed: 17890755.
  14. Beloosesky Y, Hendel D, Weiss A, Hershkovitz A, Grinblat J et al. (2007) Cytokines and C-reactive protein production in hip-fracture- operated elderly patients. J Gerontol A Biol Sci Med Sci 62: 420-426. doi:10.1093/gerona/62.4.420. PubMed: 17452737. · DOI
  15. van Munster BC, Korevaar JC, Zwinderman AH, Levi M, Wiersinga WJ et al. (2008) Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc 56: 1704-1709. doi:10.1111/j. 1532-5415.2008.01851.x. PubMed: 18691278. · DOI · Paper page
  16. MacLullich AM, Edelshain BT, Hall RJ, de Vries A, Howie SE et al. (2011) Cerebrospinal Fluid Interleukin-8 Levels Are Higher in People with Hip Fracture with Perioperative Delirium Than in Controls. J Am Geriatr Soc 59: 1151-1153. doi:10.1111/j.1532-5415.2011.03428.x. PubMed: 21668926. · DOI
  17. O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J et al. (2009) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14: 511-522. doi:10.1038/sj.mp.4002148. PubMed: 18195714. · DOI · Paper page
  18. Field RH, Gossen A, Cunningham C (2012) Prior pathology in the basal forebrain cholinergic system predisposes to inflammation induced working memory deficits: reconciling inflammatory and cholinergic hypotheses of delirium. J Neurosci 32: 6288-6294. doi:10.1523/ JNEUROSCI.4673-11.2012. PubMed: 22553034. · DOI
  19. Cunningham C (2013) Microglia and neurodegeneration: The role of systemic inflammation. Glia 61: 71-90. doi:10.1002/glia.22350. PubMed: 22674585. · DOI · Paper page
  20. Murray CL, Skelly DT, Cunningham C (2011) Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1beta and IL-6. J Neuroinflammation 8: 50. doi:10.1186/1742-2094-8-50. PubMed: 21586125. · DOI
  21. Field R, Campion S, Warren C, Murray C, Cunningham C (2010) Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav Immun 24: 996-1007. doi:10.1016/j.bbi.2010.04.004. PubMed: 20399848. · DOI
  22. Chen L-C, Chen C-C, Liang Y, Tsang N-M, Chang Y-S et al. (2011) A novel role for TNFAIP2: its correlation with invasion and metastasis in nasopharyngeal carcinoma. Mod Pathol 24: 175-184. doi:10.1038/ modpathol.2010.193. PubMed: 21057457. · DOI
  23. Cunningham O, Campion S, Perry VH, Murray C, Sidenius N et al. (2009) Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation. Glia 57: 1802-1814. doi:10.1002/ glia.20892. PubMed: 19459212. · DOI
  24. Koj A (1996) Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta 1317: 84-94. doi:10.1016/ S0925-4439(96)00048-8. PubMed: 8950192. · DOI
  25. Perry VH, Cunningham C, Holmes C (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 7: 161-167. doi:10.1038/nri2015. PubMed: 17220915. · DOI · Paper page
  26. Cunningham C, Campion S, Lunnon K, Murray CL, Woods JF et al. (2009) Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry 65: 304-312. doi:10.1016/j.biopsych.2008.07.024. PubMed: 18801476. · DOI · Paper page
  27. Church LD, Cook GP, McDermott MF (2008) Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol 4: 34-42. doi:10.1038/ncpneuro0683. PubMed: 18172447. · DOI
  28. Marinkovic S, Jahreis GP, Wong GG, Baumann H (1989) IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 142: 808-812. PubMed: 2464026.
  29. Wang J, Dunn AJ (1998) Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem Int 33: 143-154. doi:10.1016/S0197-0186(98)00016-3. PubMed: 9761458. · DOI
  30. Harden LM, du Plessis I, Roth J, Loram LC, Poole S et al. (2011) Differences in the relative involvement of peripherally released interleukin (IL)-6, brain IL-1β and prostanoids in mediating lipopolysaccharide-induced fever and sickness behavior. Psychoneuroendocrinology 36: 608-622. doi:10.1016/j.psyneuen. 2010.09.003. PubMed: 20926198. · DOI
  31. Harden LM, du Plessis I, Poole S, Laburn HP (2006) Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior. Physiol Behav 89: 146-155. doi:10.1016/j.physbeh.2006.05.016. PubMed: 16842830. · DOI
  32. Nilsberth C, Elander L, Hamzic N, Norell M, Lonn J et al. (2009) The role of interleukin-6 in lipopolysaccharide-induced fever by mechanisms independent of prostaglandin E2. Endocrinology 150: 1850-1860. doi: 10.1210/en.2008-0806. PubMed: 19022895. · DOI
  33. Laflamme N, Rivest S (1999) Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J Neurochem 73: 309-321. PubMed: 10386984.
  34. Rivest S (2001) How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 26: 761-788. doi:10.1016/ S0306-4530(01)00064-6. PubMed: 11585678. · DOI
  35. Ceciliani F, Giordano A, Spagnolo V (2002) The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett 9: 211-223. doi:10.2174/0929866023408779. PubMed: 12144517. · DOI
  36. Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB et al. (1989) Antibodies to cachectin/tumor necrosis factor reduce interleukin 1beta and interleukin 6 appearance during lethal bacteremia. J Exp Med 170: 1627-1633. doi:10.1084/jem.170.5.1627. PubMed: 2809510. · DOI
  37. Fantuzzi G, Dinarello C (1996) The inflammatory response in interleukin-1beta-deficient mice: comparison with other cytokine-related knock-out mice. J Leukoc Biol 59: 489-493. PubMed: 8613694.
  38. Granowitz EV, Porat R, Mier JW, Orencole SF, Callahan MV et al. (1993) Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans. Blood 82: 2985-2990. PubMed: 8219190.
  39. Teeling JL, Cunningham C, Newman TA, Perry VH (2010) The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav Immun 24: 409-419. doi:10.1016/j.bbi. 2009.11.006. PubMed: 19931610. · DOI · Paper page
  40. Nadjar A, Combe C, Laye S, Tridon V, Dantzer R et al. (2003) Nuclear factor kappa B nuclear translocation as a crucial marker of brain response to interleukin-1. A study in rat and interleukin-1 type I deficient mouse. J Neurochem 87: 1024-1036. PubMed: 14622131.
  41. Gosselin D, Rivest S (2007) Role of IL-1 and TNF in the brain: Twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav Immun 21: 281-289. doi:10.1016/j.bbi. 2006.12.004. PubMed: 17275255. · DOI
  42. Zhang J, Rivest S (2003) Is survival possible without arachidonate metabolites in the brain during systemic infection? News Physiol Sci 18: 137-142. PubMed: 12869612.
  43. Nadjar A, Bluthe RM, May MJ, Dantzer R, Parnet P (2005) Inactivation of the cerebral NFkappaB pathway inhibits interleukin-1beta-induced sickness behavior and c-Fos expression in various brain nuclei. Neuropsychopharmacology 30: 1492-1499. doi:10.1038/sj.npp. 1300755. PubMed: 15900319. · DOI · Paper page
  44. Margheri F, Chilla A, Laurenzana A, Serrati S, Mazzanti B et al. (2011) Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae. Blood 118: 3743-3755. doi:10.1182/blood-2011-02-338681. PubMed: 21803847. · DOI
  45. Stach K, Nguyen XD, Lang S, Elmas E, Weiss C et al. (2012) Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand. Cardiol J 19: 20-28. doi:10.5603/CJ.2012.0005. PubMed: 22298164. · DOI
  46. Goehler L, Gaykema R, Hammack S, Maier S, Watkins L (1998) Interleukin-1 induces c-Fos immunoreactivity in primary afferent neurons of the vagus nerve. Brain Res 804: 306-310. doi:10.1016/ S0006-8993(98)00685-4. PubMed: 9757071. · DOI
  47. Chakravarty S, Herkenham M (2005) Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J Neurosci 25: 1788-1796. doi:10.1523/JNEUROSCI.4268-04.2005. PubMed: 15716415. · DOI · Paper page
  48. Cunningham C, Maclullich AM (2013) At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response. Brain Behav Immun 28: 1-13. doi: 10.1016/j.bbi.2012.07.012. PubMed: 22884900. · DOI
  49. Clark K, Plater L, Peggie M, Cohen P (2009) Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ϵ. J Biol Chem 284: 14136-14146. doi:10.1074/jbc.M109.000414. PubMed: 19307177. · DOI
  50. Clark K, Peggie M, Plater L, Sorcek RJ, Young ER et al. (2011) Novel cross-talk within the IKK family controls innate immunity. Biochem J 434: 93-104. doi:10.1042/BJ20101701. PubMed: 21138416. · DOI · Paper page
  51. Colonna M (2007) TLR pathways and IFN-regulatory factors: to each its own. Eur J Immunol 37: 306-309. doi:10.1002/eji.200637009. PubMed: 17273997. · DOI
  52. Kawai T, Takeuchi O, Fujita T, Inoue J-i, Mühlradt PF et al. (2001) Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes. J Immunol 167: 5887-5894. PubMed: 11698465.
  53. Bell MD, Taub DD, Perry VH (1996) Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience 74: 283-292. doi: 10.1016/0306-4522(96)00083-8. PubMed: 8843093. · DOI
  54. Anthony D, Dempster R, Fearn S, Clements J, Wells G et al. (1998) CXC chemokines generate age-related increases in neutrophil- mediated brain inflammation and blood-brain barrier breakdown. Curr Biol 8: 923-926. doi:10.1016/S0960-9822(07)00373-9. PubMed: 9707404. · DOI
  55. Dzenko K, Song L, Ge S, Kuziel W, Pachter J (2005) CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2. Microvasc Res 70: 53-64. doi:10.1016/j.mvr.2005.04.005. PubMed: 15927208. · DOI
  56. Echeverry S, Shi X, Rivest S, Zhang J (2011) Peripheral nerve injury alters blood-spinal cord barrier functional and molecular integrity through a selective inflammatory pathway. J Neurosci Off J Soc Neurosci 31: 10819-10828. doi:10.1523/JNEUROSCI.1642-11.2011. · DOI
  57. Adler M, Rogers T (2005) Are chemokines the third major system in the brain? J Leukoc Biol 78: 1204-1209. doi:10.1189/jlb.0405222. PubMed: 16204637. · DOI
  58. Rostène W, Dansereau M-A, Godefroy D, Van Steenwinckel J, Reaux- Le Goazigo A et al. (2011) Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system. J Neurochem 118: 680-694. doi:10.1111/j. 1471-4159.2011.07371.x. PubMed: 21722132. · DOI
  59. Banisadr G, Gosselin R-D, Mechighel P, Kitabgi P, Rostène W et al. (2005) Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol 489: 275-292. doi:10.1002/cne.20598. PubMed: 16025454. · DOI
  60. Conductier G, Blondeau N, Guyon A, Nahon J-L, Rovère C (2010) The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J Neuroimmunol 224: 93-100. doi: 10.1016/j.jneuroim.2010.05.010. PubMed: 20681057. · DOI
  61. Vallès A, Grijpink-Ongering L, de Bree F, Tuinstra T, Ronken E (2006) Differential regulation of the CXCR2 chemokine network in rat brain trauma: implications for neuroimmune interactions and neuronal survival. Neurobiol Dis 22: 312-322. doi:10.1016/j.nbd.2005.11.015. PubMed: 16472549. · DOI
  62. Cho J, Gruol D (2008) The chemokine CCL2 activates p38 mitogen- activated protein kinase pathway in cultured rat hippocampal cells. J Neuroimmunol 199: 94-103. doi:10.1016/j.jneuroim.2008.05.011. PubMed: 18584881. · DOI
  63. Zhou Y, Tang H, Liu J, Dong J, Xiong H (2011) Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J Neurochem 116: 406-414. doi:10.1111/j. 1471-4159.2010.07121.x. PubMed: 21105875. · DOI
  64. Campbell SJ, Meier U, Mardiguian S, Jiang Y, Littleton ET et al. (2010) Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE. Brain Behav Immun 24: 738-746. doi:10.1016/j.bbi.2010.01.011. PubMed: 20138139. · DOI
  65. Giovannelli A, Limatola C, Ragozzino D, Mileo A, Ruggieri A et al. (1998) CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. J Neuroimmunol 92: 122-132. doi:10.1016/ S0165-5728(98)00192-1. PubMed: 9916887. · DOI
  66. Xia M, Hyman B (2002) GROalpha/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation-a role in Alzheimer's disease? J Neuroimmunol 122: 55-64. doi:10.1016/ S0165-5728(01)00463-5. PubMed: 11777543. · DOI
  67. Puma C, Danik M, Quirion R, Ramon F, Williams S (2001) The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J Neurochem 78: 960-971. doi:10.1046/j. 1471-4159.2001.00469.x. PubMed: 11553670. · DOI
  68. Watson K, Fan GH (2005) Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Mol Pharmacol 67: 757-765. PubMed: 15608143.
  69. Merkel S, Alexander S, Zufall E, Oliver J, Huet-Hudson Y (2001) Essential role for estrogen in protection against Vibrio vulnificus- induced endotoxic shock. Infect Immun 69: 6119-6122. doi:10.1128/IAI. 69.10.6119-6122.2001. PubMed: 11553550. · DOI
  70. Moxley G, Posthuma D, Carlson P, Estrada E, Han J et al. (2002) Sexual dimorphism in innate immunity. Arthritis Rheum 46: 250-258. doi:10.1002/1529-0131(200201)46:1. PubMed: 11817599. · DOI · Paper page
  71. Marriott I, Bost K, Huet-Hudson Y (2006) Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility. J Reprod Immunol 71: 12-27. doi: 10.1016/j.jri.2006.01.004. PubMed: 16574244. · DOI
  72. Kahlke V, Angele M, Ayala A, Schwacha M, Cioffi W et al. (2000) Immune dysfunction following trauma-haemorrhage: influence of gender and age. Cytokine 12: 69-77. doi:10.1006/cyto.1999.0511. PubMed: 10623445. · DOI
  73. Walker Q, Cabassa J, Kaplan K, Li S, Haroon J et al. (2001) Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy. Neuropsychopharmacol Off Publ American College Of Neuropsychopharmacology 25: 118-130. doi:10.1016/ S0893-133X(00)00248-7. · DOI
  74. Walker Q, Francis R, Cabassa J, Kuhn C (2001) Effect of ovarian hormones and estrous cycle on stimulation of the hypothalamo- pituitary-adrenal axis by cocaine. J Pharmacol Exp Ther 297: 291-298. PubMed: 11259556.
  75. Seok J, Warren H, Cuenca A, Mindrinos M, Baker H et al. (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110: 3507-3512. doi: 10.1073/pnas.1222878110. PubMed: 23401516. · DOI · Paper page
  76. Swiergiel AH, Dunn AJ (2007) Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav 86: 651-659. doi:10.1016/ j.pbb.2007.02.010. PubMed: 17360031. 122. · DOI
  77. Elander L, Engstrom L, Hallbeck M, Blomqvist A (2007) IL-1beta and LPS induce anorexia by distinct mechanisms differentially dependent on microsomal prostaglandin E synthase-1. Am J Physiol Regul Integr Comp Physiol 292: R258-R267. PubMed: 16946079. 123. Mormède C, Castanon N, Médina C, Dantzer R (2003) Conditioned place aversion with interleukin-1[beta] in mice is not associated with activation of the cytokine network. Brain Behav Immun 17: 110-120. doi:10.1016/S0889-1591(02)00054-5. PubMed: 12676573. 124. Bluthé RM, Pawlowski M, Suarez S, Parnet P, Pittman Q et al. (1994) Synergy between tumor necrosis factor α and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 19: 197-207. doi:10.1016/0306-4530(94)90009-4. PubMed: 8190839. · DOI

Cited by

Sorted by citations

Authors
Skelly, D. T., Hennessy, E., Dansereau, M.-A., & Cunningham, C.
Affiliations
Virginia Commonwealth University (US)
Corresponding author
Cunningham, Colm
Venue
PLoS ONE
Published
2013-12-09
Volume
8
Issue
12
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2629368404
Cited by
77
References
20
Citations by year
2026: 4 · 2025: 4 · 2024: 9 · 2023: 8 · 2022: 13 · 2021: 10 · 2020: 7 · 2019: 12 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 3
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Wellcome Trust
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Thermal Regulation in Medicine
Keywords
systemic inflammation, lipopolysaccharide, IL-1β, TNF-α, interleukin-6, inflammatory cytokines, neuroinflammation, core body temperature, hypothermia, acute phase response, CXCL1, MCP-1, cyclooxygenase-2, NF-κB, amygdala, C57BL/6 mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review